Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-341-3 | CAS number: 329-01-1
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
There are no reproductive or developmental toxicity studies of alpha,alpha,alpha-trifluoro-3-tolyl isocyanate available. Since inhaled alpha,alpha,alpha-trifluoro-3-tolyl isocyanate vapour will react primarily with lung tissue so that other systemic organ systems or tissues would be affected only at exposure concentrations that produce sufficient lung toxicity. But the propensity of talpha,alpha,alpha-trifluoro-3-tolyl isocyanate to cause lung effects consequently led to secondary effects such as hypoxia that could influence developmental endpoints. Therefore it is not expected to yield useful information from a reproductive or developmental toxicity study of alpha,alpha,alpha-trifluoro-3-tolyl isocyanate vapor inhalation. Thus reproductive toxicity cannot be excluded, but it seems to be unlikely at non irritant alpha,alpha,alpha-trifluoro-3-tolyl isocyanate exposure concentrations.
Short description of key information:
no data
Effects on developmental toxicity
Description of key information
no data
Additional information
There are no reproductive or developmental toxicity studies of alpha,alpha,alpha-trifluoro-3-tolyl isocyanate available. Since inhaled alpha,alpha,alpha-trifluoro-3-tolyl isocyanate vapour will react primarily with lung tissue so that other systemic organ systems or tissues would be affected only at exposure concentrations that produce sufficient lung toxicity. But the propensity of talpha,alpha,alpha-trifluoro-3-tolyl isocyanate to cause lung effects consequently led to secondary effects such as hypoxia that could influence developmental endpoints. Therefore it is not expected to yield useful information from a reproductive or developmental toxicity study of alpha,alpha,alpha-trifluoro-3-tolyl isocyanate vapor inhalation. Thus reproductive toxicity cannot be excluded, but it seems to be unlikely at non irritant alpha,alpha,alpha-trifluoro-3-tolyl isocyanate exposure concentrations.
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
